Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine for euthyroid pregnant women with positive TPO antibodies
IRCT2013100114849N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of levothyroxine sodium in Pregnancy loss, Preterm labor (PTL), low birth weight (LBW) and 3 more (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Spontaneous abortion rate, Preterm labor incidence and 4 more. Started Nov 2013; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
Pregnancy lossPreterm labor (PTL)low birth weight (LBW)intrauterine growth restriction (IUGR)Rupture of amniotic membranes (PROM)
Beyond the preview
Go deeper on IRCT2013100114849N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013100114849N1.